Back to EPRX
GOLDMAN SACHS GROUP INC → EPRX
GOLDMAN SACHS GROUP INC EPRX Position History
Eupraxia Pharmaceuticals Inc. • Healthcare
Quarters held
7
Latest value
$384K
Q2 2026
Peak value
$438K
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $113K |
| Q2 2025 | $229K |
| Q3 2025 | $237K |
| Q4 2025 | $438K |
| Q4 2025 | $438K |
| Q1 2026 | $384K |
| Q2 2026 | $384K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $384K | 58.1K | — | — |
| Q1 2026 | $384K | 53.1K | — | — |
| Q4 2025 | $438K | 58.1K | — | — |
| Q4 2025 | $438K | 58.1K | — | — |
| Q3 2025 | $237K | 40.1K | — | — |
| Q2 2025 | $229K | 39.8K | — | — |
| Q1 2025 | $113K | 34.5K | — | — |
Other funds holding EPRX
$12.9M
$12.3M